ID: ALA5194883

Max Phase: Preclinical

Molecular Formula: C14H19NO2S2

Molecular Weight: 297.45

Associated Items:

Representations

Canonical SMILES:  O=S(=O)(NC1C2CC3CC(C2)CC1C3)c1cccs1

Standard InChI:  InChI=1S/C14H19NO2S2/c16-19(17,13-2-1-3-18-13)15-14-11-5-9-4-10(7-11)8-12(14)6-9/h1-3,9-12,14-15H,4-8H2

Standard InChI Key:  YHYAAMWVCSUWGH-UHFFFAOYSA-N

Associated Targets(Human)

Gamma-secretase 4915 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 297.45Molecular Weight (Monoisotopic): 297.0857AlogP: 2.85#Rotatable Bonds: 3
Polar Surface Area: 46.17Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 8.79CX Basic pKa: CX LogP: 2.93CX LogD: 2.91
Aromatic Rings: 1Heavy Atoms: 19QED Weighted: 0.93Np Likeness Score: -1.51

References

1. Kumar N, Kumar V, Anand P, Kumar V, Ranjan Dwivedi A, Kumar V..  (2022)  Advancements in the development of multi-target directed ligands for the treatment of Alzheimer's disease.,  61  [PMID:35398739] [10.1016/j.bmc.2022.116742]

Source